(JAMA Network) The risk of serotonin syndrome in patients prescribed both triptans for migraine and antidepressants appears to be low, which may suggest an advisory from the US Food and Administration on that risk should be reconsidered.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2F51EwN
No comments:
Post a Comment